California Wegovy Side Effects Lawyer

DIABETES AND WEIGHT LOSS DRUG STOMACH PARALYSIS LAWSUIT

If you’ve been prescribed Wegovy for weight management and are now facing adverse reactions, know that you’re not isolated in this. We’ve observed numerous Californians coming forward with complications post-Wegovy (semaglutide) administration. As you contemplate initiating a Wegovy-related lawsuit in California, our dedicated team of pharmaceutical liability attorneys is ready to assist. It’s essential to select a proficient Wegovy adverse reactions attorney. Connect with us, and we’ll introduce you to top-tier legal representation suited for your case.

Wegovy, bearing the active ingredient semaglutide, is an FDA-approved injectable prescribed primarily for addressing obesity. It operates by emulating a hormone influencing the brain’s regions responsible for appetite regulation. Classified under the glucagon-like peptide-1 (GLP-1) receptor agonists, this drug has been employed in treating diabetes too.

The efficacy of semaglutide in weight management has been making headlines. Brands like Wegovy, Ozempic, Rybelsus, Trulicity, Mounjaro, and Saxenda, initially introduced for diabetic patients, are now touted as groundbreaking weight loss solutions. Although tailored for individuals with obesity, it’s concerning to note that numerous non-obese individuals are opting for it to achieve greater weight reduction. But, as history has repeatedly shown with pharmaceuticals, there are inherent risks. There’s an escalating number of adverse effect reports, and unsurprisingly, lawsuits related to Wegovy are emerging nationwide, including here in California.

FILING A LAWSUIT IN CALIFORNIA AGAINST THE MANUFACTERS OF WEGOVY

Wegovy originates from Novo Nordisk, a corporation based in Denmark. If you, as a Californian, have faced detrimental side effects from semaglutide, you might consider legal avenues against Novo Nordisk. Potential action could involve a product liability claim, founded on allegations like negligence, inadequate risk notification, production defects, or other pertinent legal bases in accordance with California law. If you or a family member experiences pronounced side effects post-Wegovy consumption, the thought of litigating against the producing company is justified.

Fill in this form for a free case review:

SHOULD YOU FILE AN INDIVIDUAL CLAIM OR JOIN A CLASS ACTION?

While joining a Wegovy class action might be a consideration, often, in the face of pronounced injuries, advancing an individual suit proves more advantageous under California law. This path might not only expedite a resolution but also possibly yield a more generous settlement figure.

WHAT ARE THE MOST COMMON ADVERSE EFFECTS OF WEGOVY?

Individuals on Wegovy experiencing ongoing digestive symptoms such as nausea, vomiting, bloating, or abdominal discomfort should consult their physician to assess potential gastric paralysis or delayed stomach emptying. The FDA has received reports of significant health complications. Here are some of the gravest potential adverse reactions linked to Wegovy (semaglutide):

• Gastroparesis: This condition, commonly known as stomach paralysis, hinders the stomach’s ability to effectively evacuate its contents.
• Pancreatitis: This entails the pancreas becoming inflamed. Though infrequent, it’s severe. Indications include intense abdominal discomfort, nausea, and vomiting. Immediate medical care is imperative.
• Gallbladder Complications: Using Wegovy might heighten the likelihood of developing gallstones or gallbladder inflammation. Potential symptoms encompass intense abdominal pain, fever, and skin discoloration to yellow.
• Kidney Issues: Semaglutide has been linked to kidney damage in specific instances. Warning signs could involve nausea, vomiting, appetite loss, and diminished kidney functionality.
• Hypoglycemia (Low Blood Sugar): In diabetic patients concurrently receiving insulin or other blood sugar-reducing medications, Wegovy can lead to perilously low blood sugar. This might manifest as confusion, excessive perspiration, or rapid heart rate.
• Allergic Manifestations: A subset of individuals might experience acute allergic responses to semaglutide, displaying symptoms like skin rashes, swelling, or respiratory difficulties.
• Thyroid Tumors: Wegovy, as a GLP-1 receptor agonist, is correlated with an elevated risk of thyroid C-cell tumors, encompassing medullary thyroid carcinoma.
• Diabetic Retinopathy Aggravation: In certain diabetic individuals, Wegovy can exacerbate pre-existing diabetic ocular conditions.
• Visual Complications: There’s a possibility of vision alterations or ocular issues, especially among those previously diagnosed with diabetic retinopathy.

Hospitals in California Where Your Side Effects May Have Been Treated

Were you hospitalized due to your side effects at any of the hospitals below? If so, call our office today to get your free consultation.